SARS-CoV-2 infection can induce excessive inflammatory responses in seropositive RA patients by activating the NLRP3/CASP1 pyroptosis pathway and may enhance autoantibody production through similar mechanisms (82). This evidence concerns the gene NLRP3 and rheumatoid arthritis.